Primary Double-Strike Therapy for Cancers to Overcome EGFR Kinase Inhibitor Resistance: Proposal from the Bench

Documenti analoghi

• Drug Tolerance to EGFR Tyrosine Kinase Inhibitors in Lung Cancers with EGFR Mutations
  di: Suda, Kenichi, et al.
  Pubblicazione: (2021)
• Heterogeneity in Tumors and Resistance to EGFR TKI Therapy—Letter
  di: Suda, Kenichi, et al.
  Pubblicazione: (2016)
• Heterogeneity of EGFR Aberrations and Correlation with Histological Structures: Analyses of Therapy-Naive Isogenic Lung Cancer Lesions with EGFR Mutation
  di: Suda, Kenichi, et al.
  Pubblicazione: (2016)
• Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
  di: Suda, Kenichi, et al.
  Pubblicazione: (2013)
• Ability of the Met Kinase Inhibitor Crizotinib and New Generation EGFR Inhibitors to Overcome Resistance to EGFR Inhibitors
  di: Nanjo, Shigeki, et al.
  Pubblicazione: (2013)